To you, it might be green pond scum. But to some researchers, algae is a vehicle for making key pharmaceutical and industrial compounds. A recent patent could give one company a virtual corner on the biotech algae market. The patent, issued to Martek Biosciences of Columbia, Md., outlines a process to grow non-algal genes in algal cells. The process takes place in a few hours, in contrast to the months it takes to introduce genes into transgenic crop plants like corn or tobacco. The process could also help model the large-scale production of chemicals in crops in fast-growing algae. Martek is working on algal production methods for docosahexaenoic acid, a baby formula ingredient that aids mental development.
The inside story of how ChatGPT was built from the people who made it
Exclusive conversations that take us behind the scenes of a cultural phenomenon.
ChatGPT is about to revolutionize the economy. We need to decide what that looks like.
New large language models will transform many jobs. Whether they will lead to widespread prosperity or not is up to us.
Sam Altman invested $180 million into a company trying to delay death
Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.
GPT-4 is bigger and better than ChatGPT—but OpenAI won’t say why
We got a first look at the much-anticipated big new language model from OpenAI. But this time how it works is even more deeply under wraps.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.